MedTrace Logo

An Observational Study in Patients With Mild to Moderate COVID-19

NCT05366244 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-05-19

No results posted yet for this study

Summary

The purpose of this study was to observe real-world disease progression in mild-moderate COVID-19 patients with at least one risk factor for serve COVID-19 illness or death.

Conditions

Sponsors & Collaborators

  • ShuGuang Hospital

    collaborator OTHER

  • Shanghai Pudong Hospital

    lead OTHER

Principal Investigators

  • Minghua Yu · Shanghai Pudong Hospital

  • Yueqiu Gao · ShuGuang Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-02
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05366244 on ClinicalTrials.gov